Pexidartinib (PLX3397) IC50 for Cell-based and Cell-free Assays

Jump to:

• Pexidartinib (PLX3397) Mechanism of Action: CSF1R Inhibition in Synovial Macrophage Research
• Pexidartinib (PLX3397) Working Concentration | Cell Culture | Treatment
• Pexidartinib (PLX3397) Solubility in DMSO
• Pexidartinib (PLX3397) Storage & Stability
• Pexidartinib (PLX3397) VS PLX5622
• Pexidartinib (PLX3397) Molecular Weight | Chemical Structure | Stock Solution
• Pexidartinib (PLX3397) Sigma (AMBH2D6FF0AB)? Try a better option.
• Pexidartinib (PLX3397) MCE (HY-16749)? Try a better option.
• Pexidartinib (PLX3397) Cayman (18271)? Try a better option.
• Pexidartinib (PLX3397) Abmole (M4867)? Try a better option.
• Pexidartinib (PLX3397) Tocris (7590)? Try a better option.
• Pexidartinib (PLX3397) SDS｜MSDS
• Pexidartinib (PLX3397) in Tenosynovial Giant Cell Tumor (TGCT) Therapeutics
• Pexidartinib (PLX3397) in Neuroinflammation and Microglia Depletion
• Pexidartinib (PLX3397) in Tumor Microenvironment and Macrophage Polarization